Robert Lorne Abel net worth and biography

Robert Abel Biography and Net Worth

Insider of Schrodinger

Executive Vice President and Chief Computational Scientist, joined Schrödinger in 2009, is responsible for advancing Schrödinger’s computational science platform. He also leads the computational chemistry team within Schrödinger’s drug discovery group. Robert obtained his PhD from Columbia University, where he was awarded NSF and DHS research fellowships. His thesis work with Professor Richard Friesner involved developing methods to quantify the role of solvent in protein-ligand binding. Robert has co-authored multiple patent applications, and continues to publish extensively on a wide variety of topics in computational chemistry.

What is Robert Lorne Abel's net worth?: The estimated net worth of Robert Lorne Abel is at least $619.34 thousand as of March 4th, 2026. Dr. Abel owns 55,897 shares of Schrodinger stock worth more than $619,339 as of March 29th. This net worth evaluation does not reflect any other assets that Dr. Abel may own. Learn More about Robert Lorne Abel's net worth.
How do I contact Robert Lorne Abel?: The corporate mailing address for Dr. Abel and other Schrodinger executives is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. Schrodinger can also be reached via phone at 212-295-5800 and via email at [email protected]. Learn More on Robert Lorne Abel's contact information.
Has Robert Lorne Abel been buying or selling shares of Schrodinger?: During the last quarter, Robert Lorne Abel has sold $33,270.30 in Schrodinger stock. Most recently, Robert Lorne Abel sold 1,300 shares of the business's stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $12.81, for a transaction totalling $16,653.00. Following the completion of the sale, the insider now directly owns 55,897 shares of the company's stock, valued at $716,040.57. Learn More on Robert Lorne Abel's trading history.
Who are Schrodinger's active insiders?: Schrodinger's insider roster includes Robert Abel (Insider), Karen Akinsanya (Insider), Margaret Dugan (Insider), Ramy Farid (CEO), Jenny Herman (SVP), Rachit Jain (CFO), Rosana Kapeller-Libermann (Director), Joel Lebowitz (CFO), Kenneth Lorton (COO), Geoffrey Porges (CFO), David Shaw (Major Shareholder), Yvonne Tran (EVP), and Jorg Weiser (Director). Learn More on Schrodinger's active insiders.
Are insiders buying or selling shares of Schrodinger?: During the last twelve months, insiders at the sold shares 14 times. They sold a total of 33,458 shares worth more than $649,577.89. The most recent insider tranaction occured on March, 6th when CAO Jenny Herman sold 608 shares worth more than $7,806.72. Insiders at Schrodinger own 21.0% of the company. Learn More about insider trades at Schrodinger.
Information on this page was last updated on 3/6/2026.

Robert Lorne Abel Insider Trading History at Schrodinger

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/4/2026	Sell	1,300	$12.81	$16,653.00	55,897
2/9/2026	Sell	1,230	$13.51	$16,617.30	19,385
2/12/2024	Sell	1,205	$27.55	$33,197.75	9,340
12/13/2021	Sell	15,601	$36.28	$566,004.28
9/13/2021	Sell	15,602	$61.75	$963,423.50
6/21/2021	Sell	15,602	$74.16	$1,157,044.32	7,814
5/5/2021	Sell	15,873	$69.63	$1,105,236.99	13,377
2/5/2021	Sell	15,873	$99.13	$1,573,490.49	4,992

Robert Lorne Abel Buying and Selling Activity at Schrodinger

Schrodinger Company Overview

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Today's Range

Now: $11.08

$10.95

$11.54

50 Day Range

MA: $12.97

$11.08

$17.33

2 Week Range

Now: $11.08

$10.94

$27.63

Volume

991,801 shs

Average Volume

1,168,326 shs

Market Capitalization

$817.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57